Skip to main content

Gastrointestinal Cancer Research Program Archives

Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial

Sep. 13, 2022—Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib.

Read more


Trial for colorectal cancer drug reaches primary endpoint

Aug. 17, 2022—A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration has met its primary endpoint of overall survival in a phase 3 clinical trial.

Read more


Comprehensive framework outlined for addressing early-onset colorectal cancer research

Jan. 25, 2022—New research from Vanderbilt sets a comprehensive framework for addressing research challenges and patient needs for people under 50 with colorectal cancer.

Read more


Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform

Feb. 5, 2020—Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.

Read more


New Physician Spotlight: Cathy Eng

Nov. 1, 2019—Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, was recruited to VUMC from The University of Texas MD Anderson Cancer Center in Houston.

Read more


Colorectal cancer patients warn against dismissing early symptoms

Aug. 7, 2019—Younger patients say colorectal cancer is a disease that doesn’t follow age guidelines, so pay attention to early symptoms.

Read more


Eng named to GI cancer leadership position at VICC

Jun. 13, 2019—Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, is joining Vanderbilt-Ingram Cancer Center (VICC).

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more